{
    "code": 0,
    "data": [
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q3FY26 earnings conference call held on February 11 2026.",
            "news_id": "4e749d03-0347-4c45-82f6-f46239137614",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=252c3b99-e805-4919-8e19-f45d8cd42fe8.pdf",
            "news_date": "2026-02-11 17:28:00",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Submission of transcript of Q2FY26 earnings conference call held on November 07 2025.",
            "news_id": "7f0ca84e-4d15-4287-aadf-347cc8d2ab61",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd0db744-7bda-4476-8aa2-a966a585f084.pdf",
            "news_date": "2025-11-12 17:20:40",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY26 Earnings Conference Call held on 06.08.2025",
            "news_id": "637faded-1d83-4535-b4d1-6ee0d3f3b60b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52826fae-c519-4cf9-b9c6-fdffddcab194.pdf",
            "news_date": "2025-08-12 09:19:01",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1FY26 earnings conference call held on August 06 2025.",
            "news_id": "1f4f055c-fa10-451a-8790-68d064735a16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3be16b61-9d42-495b-b757-bf863a7551f2.pdf",
            "news_date": "2025-08-06 17:01:31",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4FY25 earnings call held on May 17 2025.",
            "news_id": "2627dac3-fde7-4f35-9ee5-6ec27a99bef4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f29b390-ce26-4f7d-b67e-740177e082de.pdf",
            "news_date": "2025-05-23 16:02:42",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 17 2025",
            "news_body": "As per enclosed letter.",
            "news_id": "b9c50f03-62e4-4982-83b4-421a2080d03e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1da01c76-4a2a-4387-9ce1-032a749e1828.pdf",
            "news_date": "2025-05-17 13:18:17",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3FY25 earnings call held on February 03 2025.",
            "news_id": "5e25a78b-e6b6-4e87-a082-46e1c11247bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c61f7528-0d84-4cf8-83c4-205fc430e94d.pdf",
            "news_date": "2025-02-07 16:59:45",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On February 03 2025 - Financial Results For The Quarter And Nine Months Ended December 30 2024",
            "news_body": "as per enclosed attachment.",
            "news_id": "8e8b5a90-5939-4814-a36d-1c82aa00fc03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cd46641-b517-401a-bfeb-4863b01bd730.pdf",
            "news_date": "2025-02-03 13:03:37",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call held on November 09, 2024",
            "news_id": "8b775a60-68e4-4c7f-becf-28b1b3898909",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5acf8bf7-f982-4505-989d-179d13318b84.pdf",
            "news_date": "2024-11-15 14:14:14",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q2 FY25 earnings conference call held on November 09, 2024",
            "news_id": "adb348e4-009b-48e6-ac56-f249c4a0e7e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be130b2f-6a61-4d65-9d13-a9402a45e02e.pdf",
            "news_date": "2024-11-09 17:45:08",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Submission of financial results for the quarter and half year ended September 30, 2024.",
            "news_id": "07232917-f447-4081-bef3-5fb2e60c417f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e8b24bd-1ae3-455f-9189-456ae05520f4.pdf",
            "news_date": "2024-11-09 12:41:46",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings conference call held on August 03, 2024.",
            "news_id": "3f85671d-e9d6-47f2-9e54-c222dafc8cb4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8a86a2b-ea18-4b51-8089-6faf97284ea9.pdf",
            "news_date": "2024-08-08 18:07:15",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY25 earnings conference call held on August 03, 2024.",
            "news_id": "4cb74612-ab1d-4ce5-b769-9b987f64108d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f19a51e-e786-4b06-a6b0-07321e9dd575.pdf",
            "news_date": "2024-08-03 16:10:34",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "As per enclosed letter.",
            "news_id": "1fcef0bf-d650-495f-8c74-2bc23b632299",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7544b38b-1667-46db-8513-8288e10cb37b.pdf",
            "news_date": "2024-08-03 12:10:27",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4FY24 earnings call held on May 25, 2024.",
            "news_id": "56b7b2f2-1a00-4699-a18b-a572ec8c26ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35db8a1c-4697-473d-b6a4-8670ba6b5e43.pdf",
            "news_date": "2024-05-30 16:24:45",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Submission of weblink of Audio recording of earnings conference call Q4FY2024 held on May 25, 2024.",
            "news_id": "86a53890-6e66-43d1-bf77-df6af52c471c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f867d406-cd03-4c43-a780-c00aad2dedde.pdf",
            "news_date": "2024-05-25 16:40:57",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "As per enclosed letter.",
            "news_id": "cde07bc3-e57c-4e61-9cdc-06e43d09ef3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6408fb5-bb54-4a1b-a13e-c13ac7eb48cd.pdf",
            "news_date": "2024-05-25 12:51:15",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We herewith enclose the Transcript of earnings conference call held on February 10, 2024.",
            "news_id": "b85dd982-cb4d-431c-8a22-b360533c91d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b994e9b-5004-4081-b47e-8455d8940e2c.pdf",
            "news_date": "2024-02-16 17:04:10",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby inform that the audio recording of the earnings call for Q3FY24 held on February 10, 2024 has been updated on the Company''s website.",
            "news_id": "ddf4796e-5c47-48c5-ae56-6ecae29760e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f31a2a44-f375-4231-b7d6-673288ec9968.pdf",
            "news_date": "2024-02-10 16:07:35",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "As per enclsoed attachment.",
            "news_id": "60ff5637-ebb6-48cb-98ef-189ed7a6957c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=286c5267-05ba-418d-8348-665542515b98.pdf",
            "news_date": "2024-02-10 12:06:55",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings conference call held on November 06, 2023.",
            "news_id": "4767ab61-4071-46ac-a10c-4c6da1e6a2e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=993e7524-b3b5-4889-83a9-97caea251c8f.pdf",
            "news_date": "2023-11-11 08:42:26",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As per enclosed.",
            "news_id": "03c69a90-decf-4705-84f5-d2b6f29fbdec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fe0d780-7af6-4d51-941f-67ce89200f2e.pdf",
            "news_date": "2023-11-06 17:13:31",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "As per enclsoed.",
            "news_id": "81faed33-0515-4688-a616-265c013968a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a85f4ed-bfe6-48f5-8812-576b9237358f.pdf",
            "news_date": "2023-11-06 12:27:57",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As per enclsoed letter.",
            "news_id": "6e0ba23e-03c2-43f1-a9fa-fbe4fcc529f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=569ae845-3f2a-4a84-a5e1-644f77c8448c.pdf",
            "news_date": "2023-08-19 10:53:07",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As per enclsoed letter.",
            "news_id": "77cdb440-cb76-450d-9461-4918c51745db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0adf7f0-8675-41bf-9a58-2f3a062252b5.pdf",
            "news_date": "2023-08-14 16:33:44",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "As enclsoed",
            "news_id": "d42b526f-0ef1-4d6d-920a-9448d6365d28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=879dd693-132d-442d-8cbe-037026be3ce6.pdf",
            "news_date": "2023-08-14 12:56:35",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "As enclosed",
            "news_id": "9782098e-9a8f-4711-aae0-8fd8fededa15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a784c06d-11a3-41fd-ab8f-de1e9d723a12.pdf",
            "news_date": "2023-08-14 12:55:09",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby submit the transcript of the earnings conference call for the quarter and year ended March 31, 2023, held on May 20, 2023 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section.",
            "news_id": "d8cc736e-da8f-4284-a4ca-40188c051f87",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49127dac-7949-4649-ace1-b62bfc5dd2ac.pdf",
            "news_date": "2023-05-25 16:14:46",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of earnings conference call Q4 and full year FY23 held on May 20, 2023.",
            "news_id": "4d42ae65-f08b-4184-a3b4-987567ddba88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9936249-ab92-4ba2-8234-2e30004e004f.pdf",
            "news_date": "2023-05-20 17:24:09",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On May 20, 2023",
            "news_body": "as enclsoed<BR>",
            "news_id": "67597f69-9702-4050-afe2-a5ac96d19caa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5bcfb72-118c-487e-a500-cc763933b026.pdf",
            "news_date": "2023-05-20 13:28:45",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3FY23 earnings conference call held on February 03, 2023",
            "news_id": "d9ad395f-bc68-4ebd-8615-dba3fbcdc851",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=503f403c-2d96-42ae-832b-824d14242a34.pdf",
            "news_date": "2023-02-08 14:53:18",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Conference Call Q3FY23 Held On February 03, 2023",
            "news_body": "Further to our intimation letter dated January 25, 2023, we hereby inform that the audio recording of the earnings conference call for the quarter and nine ended December 31, 2022, held on February 03, 2023 at 14.00 Hrs IST has been uploaded on the Company's website at the following weblink:https://www.divislabs.com/wp-content/uploads/2023/02/Earnings-Call-Audio-Q3FY23.mp3",
            "news_id": "b9a8a2aa-796f-43a6-8eb2-fc72fa06efbd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaf4789d-cc1e-4c79-bd9a-442597758c0d.pdf",
            "news_date": "2023-02-03 16:29:19",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "Further to our intimation dated January 23, 2023, we would like to inform that the Board of Directors of the Company at its meeting held on February 03, 2023 has, inter alia approved the unaudited financial results for the quarter and nine months ended December 31, 2022. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the following:<BR> <BR> 1. Unaudited standalone financial results for the quarter and nine months ended December 31, 2022 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 2. Unaudited consolidated financial results for quarter and nine months ended December 31, 2022 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 3. Press Release on the said financial results of the Company.",
            "news_id": "20050e96-2a6c-4de9-8bfc-d4ca182969c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1237e7f-5fc0-403c-ba04-8b8695a09f23.pdf",
            "news_date": "2023-02-03 12:51:05",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby submit the transcript of the earnings conference call for the quarter and half year ended on September 30, 2022, held on November 07, 2022 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section.",
            "news_id": "b44df1af-a181-42ce-b401-7dd512ff95e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8114e526-7445-4a31-93b7-8a5e01acdc0c.pdf",
            "news_date": "2022-11-14 16:41:51",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Half Yearly Disclosure On Related Party Transactions For The Half Year Ended 30.09.2022",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended September 30, 2022.",
            "news_id": "143bbab5-8a16-4133-a632-9d7a36171013",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0e2fb34-7f82-46b2-8894-b2ec240bd44a.pdf",
            "news_date": "2022-11-14 16:16:12",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Further to our intimation letter dated October 28, 2022, we hereby inform that the audio recording of the earnings conference call for the quarter and half year ended September 30, 2022, held on November 07, 2022 at 14.00 Hrs IST has been uploaded on the Company's website at the following weblink:https://www.divislabs.com/wp-content/uploads/2022/11/Earnings-Call-Audio-Q2FY23_07.11.2022.mp3",
            "news_id": "a700c48f-0593-4696-98c7-1d6fc19aacd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09077ce4-6869-4b8d-bd43-a2dd365d78f3.pdf",
            "news_date": "2022-11-07 16:43:35",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 07.11.2022 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "Further to our intimation dated October 28, 2022, we would like to inform that the Board of Directors of the Company at its meeting held on November 07, 2022 has, inter alia, approved the Unaudited Financial Results for the quarter and half year ended September 30, 2022. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the following:<BR> <BR> 1. Unaudited standalone financial results for the quarter and half year ended September 30, 2022 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 2. Unaudited consolidated financial results for quarter and half year ended September 30, 2022 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 3. Press Release on the said Financial Results of the Company.<BR> The Board meeting commenced at 11.30 Hrs and concluded at 12.40 Hrs.",
            "news_id": "149f5028-fe1d-4430-91a5-5ff80cc5331b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39e2681f-f392-4949-8ce8-4b9f49afef30.pdf",
            "news_date": "2022-11-07 12:52:41",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby submit the transcript of the earnings conference call for the quarter ended June 30, 2022, held on August 12, 2022 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section. This is for your information and records.",
            "news_id": "38aadae1-3a41-42c0-8273-0d24ccec8bb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e6d5576-4363-4ef4-bb98-c872b68d7cb2.pdf",
            "news_date": "2022-08-17 14:01:16",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our intimation letter dated July 29, 2022, we hereby inform that the audio recording of the earnings call for the quarter ended June 30, 2022, held on August 12, 2022 at 14.00 Hrs IST have been uploaded on the Company's website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/08/EarningsCallAudioQ1FY23.mp3This is for your information and records.",
            "news_id": "85440800-835c-4b8d-aeaf-576bcd7ee7dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=596bc495-f30a-43ed-803f-3d2930c5f9c7.pdf",
            "news_date": "2022-08-12 16:53:06",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2022-Reg",
            "news_body": "Further to our intimation dated July 28, 2022, we would like to inform that the Board of Directors of the Company at its meeting held on Friday, August 12, 2022 has approved the Unaudited Financial Results for the quarter ended June 30, 2022. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Statement of Standalone Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon.<BR> 2. Statement of Consolidated Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon.<BR> 3. Press Release on the Financial Results of the Company.<BR> <BR> The Board meeting commenced at 11.00 Hrs and concluded at 12.15 Hrs<BR>  <BR>",
            "news_id": "4445e02c-91fd-46d7-a872-0044f8c9e151",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b66634b1-568f-4483-adc8-ba2e3ab3b704.pdf",
            "news_date": "2022-08-12 12:43:19",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Further to our intimation dated July 28, 2022, we would like to inform that the Board of Directors of the Company at its meeting held on Friday, August 12, 2022 has approved the Unaudited Financial Results for the quarter ended June 30, 2022. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Statement of Standalone Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon.<BR> 2. Statement of Consolidated Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon.<BR> 3. Press Release on the Financial Results of the Company.<BR> <BR> The Board meeting commenced at 11.00 Hrs and concluded at 12.15 Hrs",
            "news_id": "ec8d6d6b-a3d3-4b51-b6f4-495a234807ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=528e7932-53f7-4f07-a531-03c554f00074.pdf",
            "news_date": "2022-08-12 12:26:03",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Half Yearly Disclosure On Related Party Transactions For The Half Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended March 31, 2022.This is for your information and records.",
            "news_id": "dd1f62b6-95a9-4626-ac93-0e8ec43a02e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb023d59-ea22-4905-9672-c71b45186976.pdf",
            "news_date": "2022-06-01 16:43:00",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We are herewith enclosing copy of the transcript of the Company's earnings conference call for Q4 and full year FY22, held on May 23, 2022. This transcript is also uploaded on our website www.divislabs.com under Investor Relations section.This is for your information and records.",
            "news_id": "52574831-270d-442b-8313-9741478cad3b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b8880f6-0a64-459c-882e-758981cd0182.pdf",
            "news_date": "2022-05-26 12:21:28",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our intimation letter dated May 16, 2022, we hereby inform that the audio recording of the earnings call for the quarter and financial year ended March 31, 2022, held on May 23, 2022, at 14.00 Hrs IST have been uploaded on our website at the following weblink:https://www.divislabs.com/wp-content/uploads/2022/05/DIV0320220523141281.mp3 This is for your information and records.",
            "news_id": "05a07ec2-f101-47a2-92bb-b146c5e844c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adbc1c01-4bcc-4ba6-b281-08352e014fc8.pdf",
            "news_date": "2022-05-23 17:35:58",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 23, 2022",
            "news_body": "As per enclosed.",
            "news_id": "e8178e60-c373-4309-8239-790ddca5671b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf530e44-2cdf-4767-a9db-d62f2cdaa492.pdf",
            "news_date": "2022-05-23 12:33:36",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting- Audited Financial Results For The Quarter And Year Ended March 31, 2022",
            "news_body": "As per enclosed.",
            "news_id": "bf7a5b6a-751f-49f0-abe4-5852aab221a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8020e4e9-e30b-4410-b09b-698ec83a6349.pdf",
            "news_date": "2022-05-23 12:20:55",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Further to our intimation dated February 01, 2022, we would like to inform that the Board of Directors of the Company at its meeting held on February 11, 2022 has, inter alia approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2021. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the following:<BR> <BR> 1. Unaudited standalone financial results for the quarter and nine months ended December 31, 2021 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 2. Unaudited consolidated financial results for quarter and nine months ended December 31, 2021 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 3. Press Release on the said Financial Results of the Company.<BR> <BR> The Board meeting commenced at 10.30 Hrs and concluded at 11.50 Hrs<BR>  1",
            "news_id": "b907c204-6e1f-446c-9619-b0fbc60587b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7d1c8ee-a723-44db-a2b9-017ca92d3181.pdf",
            "news_date": "2022-02-11 11:59:46",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Further to our intimation dated October 28, 2021, we would like to inform that the Board of Directors of the Company at its meeting held on November 06, 2021 has, inter alia, approved the Unaudited Financial Results for the quarter and half year ended September 30, 2021. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the following:<BR> <BR> 1. Unaudited standalone financial results for the quarter and half year ended September 30, 2021 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 2. Unaudited consolidated financial results for quarter and half year ended September 30, 2021 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 3. Press Release on the said Financial Results of the Company.<BR> <BR> The Board meeting commenced at 10.00 Hrs and concluded at  11.40 Hrs.<BR>",
            "news_id": "ab72a139-ea9a-4c2e-8742-b467bf3634f0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=212f4d1a-77b7-49ce-995e-b16dd13f10eb.pdf",
            "news_date": "2021-11-06 12:02:38",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Further to our intimation dated October 28, 2021, we would like to inform that the Board of Directors of the Company at its meeting held on November 06, 2021 has, inter alia, approved the Unaudited Financial Results for the quarter and half year ended September 30, 2021. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the following:<BR> <BR> 1. Unaudited standalone financial results for the quarter and half year ended September 30, 2021 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 2. Unaudited consolidated financial results for quarter and half year ended September 30, 2021 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 3. Press Release on the said Financial Results of the Company.<BR> <BR> The Board meeting commenced at 10.00 Hrs and concluded at  11.40 Hrs.",
            "news_id": "d9c67dbc-b26b-4dea-b9d0-67523e05aea6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=194b3561-97f8-4614-b527-ade3dc8a7fd9.pdf",
            "news_date": "2021-11-06 11:48:21",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "As enclosed.",
            "news_id": "08d3b701-61e8-4888-bc2a-ecac11fabf1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73f4748f-600f-4180-b808-69bd2b52ed22.pdf",
            "news_date": "2021-08-07 12:07:02",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Half Yearly Disclosure On Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards, for the half year ended 31 March, 2021.<BR> <BR> This is for your information and records.<BR>",
            "news_id": "cb45e566-a517-4a6f-987a-e83af64a6c84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=641393f5-3e49-4304-93d9-f05c528c3e08.pdf",
            "news_date": "2021-06-01 11:35:42",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "DIVISLAB",
            "disp": "Divis Laboratories",
            "bse_code": 532488,
            "isin": "INE361B01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting- Audited Financial Results For The Quarter And Year Ended 31 March, 2021",
            "news_body": "As per enclosed.",
            "news_id": "a88659b4-5708-411d-ba06-3d35c3444049",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7c12dbf-2bbc-44cc-bedb-4258de0e3bbf.pdf",
            "news_date": "2021-05-29 13:13:42",
            "seo": "divis-laboratories-ltd",
            "ltp": 6386.5,
            "ch": 211,
            "pch": 3.416727390494697,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 10940,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}